Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168:1303–1310

Article  PubMed  Google Scholar 

Christofaro DGD, Ritti-Dias RM, Tebar WR, Werneck AO, Bittencourt MS, Cucato GG, Santos RD (2023) Are c-reactive protein concentrations affected by smoking status and physical activity levels? A longitudinal study. PLoS One 18:e0293453

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dilling H, Mombour W, Schmitt MH, Schulte-Markwort E (2016) Internationale klassifikation psychischer störungen: Icd-10 kapitel v (f). Verlag Hans Huber, Bern

Google Scholar 

Fernandes BS, Steiner J, Bernstein HG, Dodd S, Pasco JA, Dean OM, Nardin P, Goncalves CA, Berk M (2016) C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: Meta-analysis and implications. Mol Psychiatry 21:554–564

Article  CAS  PubMed  Google Scholar 

Gaebel W, Hasan A, Falkai P (2019) Awmf s3 guidelines schizophrenia of the german psychiatric association. Springer, Berlin, Germany

Google Scholar 

Gallego JA, Blanco EA, Morell C, Lencz T, Malhotra AK (2021) Complement component c4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia. Neuropsychopharmacology 46:1140–1144

Article  CAS  PubMed  Google Scholar 

Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21:1696–1709

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaros JA, Martins-de-Souza D, Rahmoune H, Rothermundt M, Leweke FM, Guest PC, Bahn S (2012) Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls. J Proteomics 76:43–55

Article  CAS  PubMed  Google Scholar 

Jorch SK, Kubes P (2017) An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med 23:279–287

Article  CAS  PubMed  Google Scholar 

Kopczynska M, Zelek W, Touchard S, Gaughran F, Di Forti M, Mondelli V, Murray R, O’Donovan MC, Morgan BP (2019) Complement system biomarkers in first episode psychosis. Schizophr Res 204:16–22

Article  PubMed  PubMed Central  Google Scholar 

Magdalon J, Mansur F, Teles ESAL, de Goes VA, Reiner O, Sertie AL (2020) Complement system in brain architecture and neurodevelopmental disorders. Front Neurosci 14:23

Article  PubMed  PubMed Central  Google Scholar 

Mayilyan KR, Weinberger DR, Sim RB (2008) The complement system in schizophrenia. Drug News Perspect 21:200–210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morgan BP, Harris CL (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 14:857–877

Article  CAS  PubMed  PubMed Central  Google Scholar 

Presumey J, Bialas AR, Carroll MC (2017) Complement system in neural synapse elimination in development and disease. Adv Immunol 135:53–79

Article  CAS  PubMed  Google Scholar 

Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Schizophrenia Working Group of the Psychiatric Genomics C, Daly MJ, Carroll MC, Stevens B, McCarroll SA (2016) Schizophrenia risk from complex variation of complement component 4. Nature 530:177–183

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-international neuropsychiatric interview (m.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for dsm-iv and icd-10. J Clin Psychiatry 59(Suppl 20):22–33;quiz 34–57

Skalniak A, Krzysciak W, Smierciak N, Szwajca M, Donicz P, Kozicz T, Pilecki M (2023) Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment. Front Psych 14:1082135

Article  Google Scholar 

Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA (2009) Common variants conferring risk of schizophrenia. Nature 460:744–747

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG (2020) Innate immune cells and c-reactive protein in acute first-episode psychosis and schizophrenia: relationship to psychopathology and treatment. Schizophr Bull 46:363–373

PubMed  Google Scholar 

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated c-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135

Article  CAS  PubMed  Google Scholar 

Wang AK, Miller BJ (2018) Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull 44:75–83

Article  PubMed  Google Scholar